HESTERBIO — Hester Biosciences Balance Sheet
0.000.00%
- IN₹14.58bn
- IN₹16.56bn
- IN₹3.11bn
- 82
- 13
- 57
- 50
Annual balance sheet for Hester Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 212 | 393 | 127 | 123 | 55.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 748 | 697 | 1,037 | 1,027 | 965 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,615 | 1,948 | 2,276 | 2,146 | 1,952 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,413 | 3,170 | 4,050 | 4,076 | 4,094 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,110 | 5,622 | 6,700 | 6,623 | 6,534 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 614 | 969 | 1,487 | 1,058 | 1,252 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,827 | 3,022 | 3,902 | 3,706 | 3,391 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,283 | 2,600 | 2,797 | 2,918 | 3,143 |
| Total Liabilities & Shareholders' Equity | 4,110 | 5,622 | 6,700 | 6,623 | 6,534 |
| Total Common Shares Outstanding |